| |
|
|
|
Anavex Life Sciences Corp.  
|
|
4.5101 -0.2 (-0.04%) |
07-13 14:28 |
|
Open: |
4.74 |
Pre close: |
4.71 |
Target:
|
5.69 
|
|
High: |
4.76 |
Low: |
4.47 |
Resistance:
|
4.87
5.66
|
|
Volume: |
488,201 |
Market Cap: |
271M |
Support:
|
3.60
3.00
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.70
|
MACD |
MACD(12,26):
|
0.15 |
|
MA(20): |
4.81  |
Signal(12,26,9): |
0.23 |
|
MA(100): |
3.77 |
Stochastic Oscillator |
%K(14,3):
|
25.71 |
|
MA(250): |
3.23 |
%D(3): |
32.48 |
|
Average Volume(K) |
3-Month: |
74262
|
52-Week |
High:
|
6.31 |
|
10-Days: |
65953 |
Low: |
2.20 |
|
RSI |
RSI(14):
|
50.60 |
Change(%): |
52.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.482 |
Return on Equity (ttm) |
-133.2 |
Shares Out. (M) |
60.08 |
|
EPS Est. Current Year |
-0.370 |
Return on Assets (ttm) |
-63.1 |
Shares Float (M) |
56.37 |
|
EPS Est. Next Year |
-0.450 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.17 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
24.24 |
|
Forward EPS |
-0.540 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
6080 |
|
Book Value (p.s.) |
0.420 |
EBITDA (p.s.) |
0.000 |
P/E |
-9.56 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
10.98 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-21.02 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-14.20 |
P/CF |
-13.18 |
|
|
|
|
|
|
